Target intelligence / Profile preview

Inhibitor of Nuclear Factor Kappa-B Kinase Subunit Beta (IKKβ)

Target
IKKβ
Molecular classification
Enzyme, Serine/threonine protein kinase
01

Overview

IKKβ is a serine/threonine protein kinase and a key regulatory subunit within the IκB kinase (IKK) complex. It is essential for the canonical NF-κB signaling pathway, activated by diverse stimuli like inflammatory cytokines, microbial products, and stress signals. Upon activation, IKKβ phosphorylates IκBs, leading to their degradation and subsequent NF-κB translocation into the nucleus to activate genes involved in immune response, inflammation, cell survival, proliferation, and apoptosis. Inhibition of IKKβ is explored as a therapeutic strategy for inflammatory diseases and cancer.

Other names
IKBKBIKK2
02

Mechanism of action

Inhibition of IKKβ prevents phosphorylation of IκBs, leading to suppression of NF-κB activation and downstream inflammatory gene expression.

03

Biological functions

Signal transductionImmune responseInflammationCell survivalCell proliferationApoptosis
04

Disease associations

CancerInflammationObesityInsulin resistance/diabetes mellitus type IICardiovascular disease
05

Safety considerations

Potential for immunosuppressionOff-target effects on other kinases

Beyond the preview

Go deeper on Inhibitor of Nuclear Factor Kappa-B Kinase Subunit Beta (IKKβ).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Inhibitor of Nuclear Factor Kappa-B Kinase Subunit Beta (IKKβ).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call